Global Alzheimer's Disease Drugs Market & Pipeline Drugs Market Analysis to 2020
Table of Contents
1. Executive Summary
2. Global Alzheimer's Disease - Drugs Market and Prevalence Analysis
2.1 Global Alzheimer's Disease - Drugs Market and Forecast (2010 - 2020)
2.2 Global Alzheimer's Disease - Prevalence and Forecast (2010 - 2020)
3. Global Alzheimer's Disease - Country Wise Market Share and Forecast (2013 - 2020)
4. Global Alzheimer's Disease - Drugs Sales and Forecast To 2020
4.1 Exelon (Rivastigmine) Sales and Forecast
4.2 Razadyne/Reminyl Sales and Forecast
4.3 Memary (Memantine) Sales and Forecast
4.4 Ebixa (Memantine) Sales and Forecast
4.5 Aricept (Donepezil) Sales and Forecast
4.6 Rivastach Sales and Forecast
4.7 Namenda (Memantine) Sales and Forecast
4.8 Nootropil (Piracetam) Sales and Forecast
4.9 Namzaric (Memantine and Donepezil) Sales and Forecast
5. Global Alzheimer's Disease - Pipeline Drugs Analysis and Sales Forecast
5.1 Solanezumab Drugs Analysis and Sales Forecast
5.1.1 About Solanezumab
5.1.2 Clinical Trials
5.1.3 Solanezumab Drugs Sales Forecast
5.2 ABT-126 Drugs Analysis and Sales Forecast
5.2.1 About ABT-126
5.2.2 Clinical Trials
5.2.3 ABT-126 Drugs Sales Forecast
5.3 Idalopirdine Drugs Analysis and Sales Forecast
5.3.1 About Idalopirdine
5.3.2 Clinical Trials
5.3.3 Idalopirdine Drugs Sales Forecast
5.4 Gantenerumab Drugs Analysis and Sales Forecast
5.4.1 About Gantenerumab
5.4.2 Clinical Trials
5.4.3 Gantenerumab Drugs Sales Forecast
5.5 Crenezumab Drugs Analysis and Sales Forecast
5.5.1 About Crenezumab
5.5.2 Clinical Trials
5.5.3 Crenezumab Drugs Sales Forecast
5.6 Lu AE58054 Drugs Analysis and Sales Forecast
5.6.1 About Lu AE58054
5.6.2 Clinical Trials
5.6.3 Lu AE58054 Drugs Sales Forecast
5.7 BIIB037 Drugs Analysis and Sales Forecast
5.7.1 About BIIB037
5.7.2 Clinical Trials
5.7.3 BIIB037 Drugs Sales Forecast
6. Alzheimer's Disease Drugs Market and Prevalence - Country Wise Analysis
6.1 United States - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.1.1 United States - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.1.2 United States - Alzheimer's Disease Prevalence and Forecast (2010 - 2020)
6.2 France - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.2.1 France - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.2.2 France - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.3 Germany - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.3.1 Germany - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.3.2 Germany - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.4 Italy - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.4.1 Italy - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.4.2 Italy - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.5 Spain - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.5.1 Spain - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.5.2 Spain - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.6 United Kingdom - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.6.1 United Kingdom - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.6.2 United Kingdom - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.7 Japan - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.7.1 Japan - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.7.2 Japan - Alzheimer's Disease Prevalence and Forecast (2012 - 2020)
6.8 China - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.8.1 China - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.8.2 China - Alzheimer's Disease Prevalence and Forecast (2010 - 2020)
6.9 India - Alzheimer's Disease Drugs Market and Prevalence Analysis
6.9.1 India - Alzheimer's Disease Drugs Market and Forecast (2013 - 2020)
6.9.2 India - Alzheimer's Disease Prevalence and Forecast (2010 - 2020)
7. Global Alzheimer's Disease Drugs Market - Major Deals Analysis
7.1 Global Alzheimer's Disease Drugs Market - Strategic Alliance
7.2 Global Alzheimer's Disease Drugs Market - Licensing Agreement
7.3 Global Alzheimer's Disease Drugs Market - Collaboration Deals
7.4 Global Alzheimer's Disease Drugs Market - Mergers and Acquisitions
8. Global Alzheimer's Disease Drugs Research - Funding Analysis
8.1 National Institute of Health (2011 - 2016)
8.2 Alzheimer's Association (2011 - 2014)
8.3 Cure Alzheimer's Fund (2008 - 2014)
8.4 Alzheimer's Drug Discovery Foundation (2008 - 2013)
8.5 BrightFocus Foundation (2010 - 2014)
9. Global Alzheimer's Disease Drug Market - Driving Factors
9.1 Growing Aging Population
9.1.1 Global Ageing Indicators
9.1.2 Population Aged 60 or Over: World and Development Regions, 1950 - 2050
9.1.3 Worldwide - Distribution of Population Aged 60 Years or Over By Broad Age Group, 1950 - 2050
9.2 Unmet Medical Needs
9.3 Strong Pipeline Candidate Expected to Drive Alzheimer's Disease Drugs Market
9.4 Future Drugs for Disease Modification in Alzheimer's Disease
10. Global Alzheimer's Disease Drug Market - Challenges
10.1 Lack of Validated Targets & Lack of Animal Models
10.2 Barriers in the Design and Implementation of Clinical Trials
10.3 Barriers in Academia & Regulatory Issues
10.4 Alzheimer's Drug Failure: Insinuation for Future R&D in Neuroscience
10.5 Costly Alzheimer's Drug Development Dissuade Drug Companies
10.6 Research Setbacks and Stepping Stones
10.7 Country Wise Barriers to Growth for Alzheimer's Disease Drugs Market
10.7.1 Unite States
10.7.2 France
10.7.3 Germany
10.7.4 United Kingdom
10.7.5 Japan
10.7.6 China
10.7.7 India
List of Figures:
Figure 2-1: Global - Alzheimer's Disease Drugs Market (Million US$), 2010 - 2014
Figure 2-2: Global - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 2-3: Global - Alzheimer's Disease Prevalence (Million), 2010 - 2014
Figure 2-4: Global - Forecast for Alzheimer's Disease Prevalence (Million), 2015 - 2020
Figure 4-1: Global - Exelon Drugs Sales (Million US$), 2003 - 2014
Figure 4-2: Global - Forecast for Exelon Drugs Sales (Million US$), 2015 - 2020
Figure 4-3: Global - Razadyne/Reminyl Drugs Sales (Million US$), 2010 - 2014
Figure 4-4: Global - Forecast for Razadyne/Reminyl Drugs Sales (Million US$), 2015 - 2020
Figure 4-5: Global - Memary Drugs Sales (Million US$), 2011 - 2014
Figure 4-6: Global - Forecast for Memary Drugs Sales (Million US$), 2015 - 2019
Figure 4-7: Global - Ebixa Drugs Sales (Million US$), 2003 - 2014
Figure 4-8: Global - Forecast for Ebixa Drugs Sales (Million US$), 2015 - 2020
Figure 4-9: Global - Aricept Drugs Sales (Million US$), 2009 - 2014
Figure 4-10: Global - Forecast for Aricept Drugs Sales (Million US$), 2015 - 2019
Figure 4-11: Global - Rivastach Drugs Sales (Million US$), 2011 - 2014
Figure 4-12: Global - Forecast for Rivastach Drugs Sales (Million US$), 2015 - 2020
Figure 4-13: Global - Namenda Drugs Sales (Million US$), 2003 - 2014
Figure 4-14: Global - Forecast for Namenda Drugs Sales (Million US$), 2015 - 2020
Figure 4-15: Global - Nootropil Drugs Sales (Million US$), 2004 - 2014
Figure 4-16: Global - Forecast for Nootropil Drugs Sales (Million US$), 2015 - 2020
Figure 4-17: Global - Forecast for Namzaric Drugs Sales (Million US$), 2015 - 2020
Figure 5-1: Global - Forecast for Solanezumab Drugs Sales (Million US$), 2017 - 2020
Figure 5-2: Global - Forecast for ABT-126 Drugs Sales (Million US$), 2017 - 2020
Figure 5-3: Global - Forecast for Idalopirdine Drugs Sales (Million US$), 2017 - 2020
Figure 5-4: Global - Forecast for Gantenerumab Drugs Sales (Million US$), 2017 - 2020
Figure 5-5: Global - Forecast for Crenezumab Drugs Sales (Million US$), 2018 - 2020
Figure 5-6: Global - Forecast for Lu AE58054 Drugs Sales (Million US$), 2017 - 2019
Figure 5-7: Global - Forecast for BIIB037 Drugs Sales (Million US$), 2019 - 2020
Figure 6-1: United States - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-2: United States - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-3: United States - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-4: United States - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-5: France - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-6: France - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-7: France - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-8: France - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-9: Germany - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-10: Germany - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-11: Germany - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-12: Germany - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-13: Italy - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-14: Italy - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-15: Italy - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-16: Italy - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-17: Spain - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-18: Spain - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-19: Spain - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-20: Spain - ForecasAlzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-21: United Kingdom - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-22: United Kingdom - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-23: United Kingdom - Alzheimer's Disease Prevalence (Thousand), 2012 - 2014
Figure 6-24: United Kingdom - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-25: Japan - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-26: Japan - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-27: Japan - Alzheimer's Disease Prevalence (Thousand), 2010 - 2014
Figure 6-28: Japan - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-29: China - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-30: China - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-31: China - Alzheimer's Disease Prevalence (Thousand), 2010 - 2014
Figure 6-32: China - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 6-33: India - Alzheimer's Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-34: India - Forecast for Alzheimer's Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-35: India - Alzheimer's Disease Prevalence (Thousand), 2010 - 2014
Figure 6-36: India - Forecast for Alzheimer's Disease Prevalence (Thousand), 2015 - 2020
Figure 8-1: National Institute of Health - Alzheimer's Disease Research Funding (Million US$), 2011 - 2014
Figure 8-2: National Institute of Health - Forecast for Alzheimer's Disease Research Funding (Million US$), 2015 - 2016
Figure 8-3: Alzheimer's Association - Alzheimer's Disease Research Funding (Million US$), 2011 - 2014
Figure 8-4: Cure Alzheimer's Fund - Alzheimer's Disease Research Funding (Million US$), 2008 - 2014
Figure 8-5: Alzheimer's Drug Discovery Foundation - Alzheimer's Disease Research Funding (Million US$), 2008 - 2013
Figure 9-1: Worldwide - Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050
Figure 9-2: Worldwide - Old-Age Dependency Ratio: Major Areas, 2009 & 2050
Figure 9-3: Worldwide - Distribution of population aged 60 years or over by broad age group, 1950 - 2050
Figure 9-4: Global - Forecast for Alzheimer's Disease Pipeline Drugs Market (Million US$), 2017 - 2020
Figure 10-1: Unsuccessful Alzheimer's Drug Development (Number), 1998 - 2011
Global Alzheimer's Disease Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......
Alzheimer's Drugs - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 97
The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......
Alzheimer Disease Drugs Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 111
This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
Alzheimer Disease Drugs Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 74
This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
Alzheimer Disease Drugs Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 239
China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......
Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Sep-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Alzheimer's Disease Drug market:
According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......
Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement......
Global Nicergoline Market Insights, Forecast to 2029
Published: 04-Jul-2023 Price: US 4900 Onwards Pages: 112
The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......
Global Oxiracetam Market Research Report 2023
Published: 21-Apr-2023 Price: US 2900 Onwards Pages: 69
Highlights
The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
